This evening we watched CVS Health rise 3.5% to a price of $73.5 per share. The large-cap Pharmaceutical Retail company is now trading -15.57% below its average target price of $87.05. Analysts have set target prices ranging from $74.0 to $104.0 per share for CVS Health, and have given the stock an average rating of buy.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.2%. The stock's short ratio is 2.15. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Vanguard Group Inc | 9% | 117,162,626 | $8,611,453,011 |
| 2023-09-30 | Blackrock Inc. | 7% | 86,733,963 | $6,374,946,280 |
| 2023-09-30 | State Street Corporation | 4% | 54,099,124 | $3,976,285,614 |
| 2023-09-30 | Capital World Investors | 3% | 40,425,071 | $2,971,242,718 |
| 2023-09-30 | Morgan Stanley | 2% | 31,114,704 | $2,286,930,744 |
| 2023-09-30 | FMR, LLC | 2% | 27,487,238 | $2,020,311,993 |
| 2023-09-30 | Dodge & Cox Inc | 2% | 26,722,982 | $1,964,139,177 |
| 2023-09-30 | Geode Capital Management, LLC | 2% | 23,930,130 | $1,758,864,555 |
| 2023-09-30 | Capital International Investors | 2% | 22,853,897 | $1,679,761,429 |
| 2023-09-30 | Bank of America Corporation | 1% | 16,410,362 | $1,206,161,607 |
